Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user is experiencing hair loss due to dermatomyositis and is considering treatments like scalp massage, hair oil, biotin, vitamin D, iron, fish oil, and possibly Rogaine. They are concerned about the emotional impact and the idea of long-term treatment.

The user improved their hair loss using finasteride, switched to dutasteride, micro-needling, Nizoral shampoo, and changed from topical to oral minoxidil, resulting in thicker hair, eyebrows, beard, and body hair. Commenters are impressed with the transformation, some mistaking the before and after photos for different people, and the user reports no side effects from the treatments.

Medication caused hair loss, which stopped after discontinuing the drugs, but hair hasn't regrown yet. The user is considering seeing a doctor for further advice and possibly using biotin supplements.

A person with alopecia universalis is considering using Xeljanz but is advised that Olumiant is more effective for their condition. They are under a dermatologist's care and should expect gradual progress, as follicles dormant for 20 years are challenging to reactivate.

A 33-year-old male restarted finasteride after stopping it to conceive, noticing hair loss, especially in the crown area. His current routine includes finasteride, minoxidil, ketoconazole, and microneedling, and he plans to continue this treatment for 18 months before making any major changes.

Young men often lack awareness of hair loss treatments like finasteride and minoxidil, causing stress and anxiety. There is a need for increased awareness and early screening to address the psychological effects of hair loss.

Hope Medicine's HMI-115 is expected to be released in 2027, with phase 3 trials currently recruiting. Concerns include the safety of targeting prolactin and the potential cost of the treatment.

Yunce Medical, a Chinese company, is developing hair multiplication technology similar to Stemson Therapeutics, with potential for quicker availability due to favorable regulations. Users express skepticism and hope for future advancements in hair loss treatments.

Betnovate and mometasone furoate were tried for scalp issues, but Zoryve and Selsun shampoo were recommended for relief. Itraconazole was suggested for stronger treatment if topicals fail.

Concerns about a potential ban on finasteride and dutasteride due to side effects, with users advocating for continued access and informed choice. Alternative treatments like pyrilutamide are also mentioned.

The conversation discusses a new hair growth treatment that showed a 14 hairs/cm2 increase in a trial, with mixed opinions on its effectiveness and potential cost. Some users are hopeful about combining it with existing treatments like oral minoxidil for better results.

Hair loss discussion includes Minoxidil, finasteride, and RU58841 treatments. Hope Medicine has a new CEO, possibly leading to HMI's termination.

Hope Medicine's announcement of the HMI-115 Phase II clinical trial for androgenetic alopecia in China; other related trials have been conducted or are ongoing in different countries, including Australia, US, and Europe. There is speculation that the product may be accepted across borders without additional testing.

Thorn Medical claims to have a stem cell-based cure for male pattern baldness, promising less scarring and better coverage than traditional hair transplants. However, skepticism remains about the effectiveness and legitimacy of these claims without concrete evidence.

The user has been taking Locklab tablets daily for three months and has experienced scalp itching and small scabbing, with possible hair regrowth. They are seeking feedback on whether others have experienced similar symptoms.

Upadacitinib is discussed as a high-risk drug for autoimmune-related hair loss. Ruxolitinib is mentioned as an existing treatment option.

New hair loss treatments are often promised but rarely materialize quickly. The user cannot tolerate minoxidil and is inquiring about alternative treatments.

Accutane can cause hair thinning in some users, with effects varying from no change to permanent hair loss. Some users reported improvements in hair and skin with treatments like Finasteride, while others experienced severe side effects, including mental health issues.

OP experienced heart issues after taking pilocarpine, which they believe interacted negatively with oral minoxidil, leading to hair loss. They stopped pilocarpine but can no longer use oral minoxidil.

A 32-year-old shared 18 months of hair loss treatment progress using 1mg finasteride, 3mg minoxidil, microneedling, a red light laser helmet, and PRP sessions, aiming for a hair transplant. Results were noticeable after a year, but the effectiveness of PRP is uncertain and varies by individual.

Hair transplantation involves a detailed consultation, preparation, and a long-term recovery process with stages like initial shedding and gradual new hair growth over months. Setting realistic expectations is crucial for patient satisfaction.

He Shou Wu (fo-ti) is discussed as a potential treatment for hair regrowth, with mixed opinions on its effectiveness. Some users report positive results, while others remain skeptical or have not noticed any changes.

The user is considering liposomal minoxidil due to non-response and side effects from other treatments. They are exploring tretinoin with topical minoxidil as an alternative.

Latanoprost is discussed as a potential hair loss treatment, noted for its synergy with minoxidil and 5-AR inhibitors, but concerns include its effectiveness on scalp hair, cost, and potential skin darkening. Some users express interest in trying latanoprost or bimatoprost despite limited real-world evidence.

A 24-year-old shared their hair loss journey, switching from a 3-in-1 medication (finasteride, minoxidil, biotin) to a stronger 4-in-1 treatment (finasteride, dutasteride, minoxidil, biotin) with no side effects and noticeable hair growth. The user also discussed using hair dye cautiously to enhance the appearance of vellus hairs.

A 25-year-old male experienced hair loss after taking breaks from oral dutasteride and minoxidil, leading to concerns about losing progress. He is advised to remain consistent with his current regimen and avoid adding spironolactone.

Hormone replacement therapy with spironolactone and estradiol significantly improved hair thickness and growth, surpassing previous treatments like dutasteride, finasteride, and minoxidil. The user experienced regrowth in receded areas and a more youthful appearance.

The user shared their hair loss progress using finasteride, topical minoxidil, dutasteride, and oral minoxidil, reporting no side effects. They noted significant improvement despite a family history of baldness.

The conversation discusses confusion over the dosage calculation of a topical solution containing 0.25% finasteride, 5% minoxidil, and 0.001% tretinoin. The user considers switching to a 0.025% finasteride solution to enhance the effects of tretinoin and minoxidil.

RU58841 powder is being discussed as a hair loss treatment, with concerns about its legitimacy and safety when purchased from Amazon. The conversation also mentions Minoxidil as a comparison in terms of price.